16_potopnyk
Ser. Khim. 2008. No 49. Part 2. P. 96–101
O ( &
)
Ph-NH-NH2
1) KOH, EtOH
8, X = S, Y = O;
9, X = O, Y = S
10, X = S, Y = O;
11, X = O, Y = S
10 ,
11 13 ,
18–21 . +
R = COOEt (14,18); C(S)NH2 (15,19); CONHPh (16,20);
!
2-( * !+,( $
5+4 1H, ': 1,33 (3 H, CH3,.2,
J = 6,8); 2,06 (3 .,
CH3); 4,20 (2 ., ,.2),
J = 6,8); 6,84 (1 H, Ph); 7,19–7,28 (4 H, Ph); 9,65 (1 H,
, %: C 63,77; H 6,32; N 13,12. C11H14N2O2. )
!
4- * (% !
-1- * !
-1H - ( $ !
-3-
5+4 1H, ': 1,42 (3 H, CH3,.2,
J = 7,2); 4,42 (2 H, CH2),
J = 7,2); 7,40 (1 H, Ph,
J = 7,6); 7,51 (2 H, Ph,
J = 7,6); 7,98 (2 H, Ph,
J = 7,6); 9,17
, %: C 63,27; H 4,84; N 11,02. C13H12N2O3.
(% !
-1- * !
-1H - ( $ !
-3-
5+4 1., ': 7,41 (1 ., Ph,
J = 8,0); 7,53 (2 ., Ph,
J = 8,0);
8,00 (2 ., Ph,
J = 8,0); 9,14 (1 .,
$ !
4-[(1,3-R2-2,4,6- (
" ( +,(
-5(2H )-
% !
]-1- * !
-1 - ( $ !
-3-
&
(6, 7).
4-[(2,4,6- (
" ( +,(
-5(2H )-
! ,
) % !
]-1- * !
-
1 - ( $!
-3- (# " !
(6).
(2 H, CH2)); 7,48 (1 H, Ph); 7,60 (2 H, Ph); 7,85 (2 H, Ph); 8,96 (1 H,
9,67 (1 H, CH=); 11,31 (1 ., NH); 11,37 (1 ., NH). !
!
4-[(1,3- , % !
-2,4,6- (
" ( +,(
-5(2H )-
!
]-1- * !
-1 - ( $ !
-3-
(
2 ), 0,32 (2,0
5+4 1H, ': 1,41 (3 H, CH3,.2); 3,12 (6 ., 2CH3N); 4,41 (2 H, CH2)); 7,49 (1 H,
Ph); 7,60 (2 H, Ph); 7,83 (2 H, Ph); 9,01 (1 H,
, %: C 58,91; H 4,55; N 14,32. C19H18N4O5. )
4-[(4(2)- "
-2(4)-
"
-1,3-
$ ! ,
-5- ! ,
) % !
]-1- * !
-1 -
(10, 11). ,
4-[(4- "
-2-
"
-1,3-
$ ! ,
-5- ! ,
) % !
]-1- * !
-1 - (
-
(10). * . = 235 °,.
4-[(2- "
-4-
"
-1,3-
$ ! ,
-5- ! ,
) % !
]-1- * !
-1 - (
-
(11). * . = 238 °,.
CH3,.2); 4,34 (2 H, CH2)); 7,41 (1 H, Ph); 7,52 (2 H, Ph); 7,92 (2 H, Ph); 8,01
!
4-[(3- % !
-5-
"
-1- * !
-1,5- , +,(
-4 - ( $ !
-4- ! ,
) % !
]-1-
* !
-1 - ( $ !
-3-
(
2 ), 0,7 (4,1
, %: C 68,17; H 4,82; N 13,55. C23H20N4O3. )
18–21.
14 –
17 8
-3- "
-3- "
-1- ( !
)-1- * !
-1 - ( $!
-3- (#
-
(18). * . = 126
– 128 °, (
CH3,.2); 1,43 (3 H, CH3,.2); 4,34 (2 H, CH2)); 4,41 (2 H, CH2)); 7,47 (1 H, Ph);
7,58 (2 H, Ph); 7,89 (2 H, Ph); 8,86 (1 H, CH=); 9,14 (1 H,
-3- "
-1- ( !
)-1- * !
-1 - ( $!
-3- (#
-
(19). * . = 188
– 190 °, (
1,43 (3 H, CH3,.2,
J = 7,2); 4,43 (2 H, CH2),
J = 7,2); 7,11 (1 H, Ph,
J = 7,6); 7,33
(2 H, Ph,
J = 7,6); 7,47 (1 H, Ph,
J = 7,6); 7,60 (2 H, Ph,
J = 7,6); 7,70 (2 H, Ph,
J = 7,6);
7,92 (2 H, Ph,
J = 7,6); 8,75 (1 H, CH=); 9,15 (1 H,
, %: C 67,21; H 4,63; N 14,05. C22H18N4O3. )
4-(3- %
-2- -
"
-1- ( !
)-1- * !
-1 - ( $ !
-3-
(20). * . = 264
– 265 °, ( +60).
(3 H, CH3,.2,
J = 7,2); 4,41 (2 H, CH2),
J = 7,2); 7,46 (1 H, Ph,
J = 7,6); 7,59 (2 H,
Ph,
J = 7,6); 7,89 (2 H, Ph,
J = 7,6); 8,70 (1 H, CH=); 9,16 (1 H,
-2-(4- * !
-1,3- $!
-2- !
) !
]-1- * !
-1 - ( $!
-3- (
-
(21). * . = 196 °, ( +60).
CH3,.2,
J = 7,2); 4,45 (2 H, CH2),
J = 7,2); 7,36 (1 ., Ph); 7,45 (3 ., Ph); 7,60
(2 ., Ph); 7,93 (2 ., Ph); 8,01 (2 ., Ph); 8,12 (1 .,
, %: C 66,84; H 4,03; N 12,86, S 7,42. C24H18N4O2S. )
$
2- * !
-2,6- , +,(
-7H - ( $ !
[3,4-d]
2, 18–21 7
5+4 1.: 7,47 (1 ., Ph,
J = 7,6); 7,58 (2 H, Ph,
J = 7,6); 8,03 (2 ., Ph,
J = 7,6); 8,26 c
1.
Bebernitz G.R., Argentieri G., Battle B., Brennan C., Balkan B., Burkey B.F. et al.
The
Effect of 1.3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice
// J. Med. Chem. 2001. Vol. 44. N 16. P. 2601–2611.
2.
Abadi A.H., Eissa A.A.H., Hassan G.S. Synthesis of novel 1,3,4-trisubstituted pyrazole
derivatives and their evaluation as antitumor and antiangiogenic agents // Chem. Pharm.
3.
Lange J.H.M., van Stuivenberg H.H., Coolen H.K.A.C., Adolfs T.J.P. et al. Bioisosteric
replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and
molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and
selective CB1 cannabinoid receptor antagonists // J. Med. Chem. 2005. Vol. 48. N 6.
4.
Mallegol T., Gmouh S., Meziane M.A.A., Blanchard-Desce M., Mongin O. Practical and
Efficient Synthesis of Tris(4-formylphenyl)amine, a Key Building Block in Materials
Chemistry // Synthesis. 2005. N 11. 4. 1771–1774.
5.
Caluwe P. Heteroannelations with o-aminoaldehydes // Tetrahedron. 1980. Vol. 36.
6.
Denison S., Hilton S.T. A Convenient Synthesis of 2-Cyano-3-Substituted Indoles
// Synlett. 2004. N 15. P 2806–2808.07.12.204
7.
Kira M.A., Abdel-Raemann M.O., Gadalla K.Z. The Vilsmeier
– Haack reaction.
III. Cyclization of hydrazones to hyrazoles // Tetrahedron Lett. 1969. N 2. P. 109–110.
8.
Kira M.A., Aboul-Enein N.M., Korkor K.Z. The Vilsmeier
– Haack reaction. IV. Reaction
of Phosphorus Oxychloride-Dimethylformamide with Semicarbazones // J. Heterocycl.
9.
Brehme R., Gründemann E., Schneider M. Reaktion von Acetophenonmono-methyl-
und -dimethylhydrazonen mit dem Vilsmeier
– Reagenz; Bildung von Pyrazol-4-
carbiminiumsalzen: ein Beitrag zum Mechanismus // J. Prakt. Chem. 2000. Bd. 7.
SYNTHESIS AND CHEMICALS CHARACTERISTICS OF ETHYL
4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE
M. Potopnyk, V. Matiychuk
Ivan Franko National University of Lviv,
Kyryla & Mefodiya Str., 6, 79005 Lviv, Ukraine
Ethyl 4-formyl-1-phenyl-1H-pyrazole-3-carboxylate was synthesized by reaction of ethyl
2-(phenylhydrazono)propanoate with the Vilsmeier–Haack complex. New methods of synthesis of
2-phenil-2,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one were suggested.
Key words : pyrazoles, Vilsmeier–Haack reagent.
Source: http://chem.lnu.edu.ua/visnyk_2008/ORGAN/16_Potopnyk.pdf
The British School, Al Rehab Location EG910 October / November 2013 CAMBRIDGE INTERNATIONAL EXAMINATIONS Pre IG/IGCSE / AS / A2 EXAMINATIONS – October/November INSTRUCTIONS TO CANDIDATES FROM EG910 PLEASE READ THE FOLLOWING INSTRUCTIONS VERY CAREFULLY Dear Candidate, You must be in possession of the following documents at all your examinations which yo
RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO NOTA: ESTE RCM FOI O ANEXADO Á DECISÃO DA COMISSÃO, RELATIVA Á SUBMISSÃO PARA ARBITRAGEM; O TEXTO VÁLIDO NA ALTURA. O TEXTO NÃO É REVISTO OU ACTUALIZADO PELA EMEA E POR ISSO NÃO REPRESENTA NECESSARIAMENTE O TEXTO ACTUAL. 1. DENOMINAÇÃO MEDICAMENTO < Renitec e denominações associadas (ver Anexo I)>, <dosagem>,
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
0-9 |